Title : The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia.

Pub. Date : 2010 Mar

PMID : 19695284






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The NMDAR contains a D-serine/glycine site on the NR1 subunit that may be a promising therapeutic target for psychiatric illness. Glycine glutamate receptor, ionotropic, NMDA1 (zeta 1) Mus musculus
2 The NMDAR contains a D-serine/glycine site on the NR1 subunit that may be a promising therapeutic target for psychiatric illness. Glycine glutamate receptor, ionotropic, NMDA1 (zeta 1) Mus musculus
3 This review outlines the complex regulation of endogenous NMDAR D-serine/glycine site agonists and explores their contribution to schizophrenia pathogenesis and their potential clinical utility. Glycine glutamate receptor, ionotropic, NMDA1 (zeta 1) Mus musculus
4 Genetic studies have associated genes influencing NMDAR D-serine/glycine site activation with an increased susceptibility to schizophrenia. Glycine glutamate receptor, ionotropic, NMDA1 (zeta 1) Mus musculus
5 Genetically modified mice with aberrant NMDAR D-serine/glycine site function model certain features of the negative and cognitive symptoms of schizophrenia, and similar behavioral abnormalities have been observed in other candidate genes models. Glycine glutamate receptor, ionotropic, NMDA1 (zeta 1) Mus musculus
6 Compounds that directly activate the NMDAR D-serine/glycine site or inhibit glycine transport have demonstrated beneficial effects in preclinical models and clinical trials. Glycine glutamate receptor, ionotropic, NMDA1 (zeta 1) Mus musculus